is under constant control of immune system and their activation with damage of various organs and systems is possible only in case of development of immunodeficiency state. This applies to pregnant women in a certain way, since they enter the period of "physiological immunodepression" and may be more prone to the pathogenic effect of TORCH infection.
Background. It is known that children with asthma are susceptible to the upper respiratory tract infections (URTIs). Likewise, respiratory infections play an essential role in the onset and progression of asthma [1] . In recent years a growing body of evidence have been obtained showing that immunological shift towards type 2 inflammatory response with overproduction of interleukins (IL) 4, 5, and 13 plays an essential role in the pathogenesis of asthma [2] . The study objectives were to investigate the serum cytokine response during viral URTIs in asthmatic children.
Materials and Methods. We enrolled a total of 95 children aged 3-7 years suffering viral URTIs on the 1-3rd day of the disease. The main group were 62 asthmatic patients with mild to moderate asthma, and 33 non-allergic patients were the controls. Serum levels of interferon α and γ (IFN-α, IFN-γ) were measured on the 1-2nd, 4-5th and 7-9th day of URTI, and serum IL-4, IL-5 and IL-13 concentrations were studied in the early and late disease.
Results. Compared to the control group, asthmatic children showed significantly lower serum levels of both interferons in the early disease (IFN-α 60.7±4.5 pg/ml and IFN-γ 4.3±0.2 pg/ml vs. 75.9±3.5 and 9.5±1.6 pg/ml in controls, resp., p< .01) and showed no significant increase in interferon levels in the middle (IFN-α 37.5±2.8 pg/ml vs. 131.0±26.8 pg/ml in controls, IFN-γ 6.6±0.4 pg/ml vs. 9.5±1.6 pg/ml in controls, p< .001) and late disease (IFN-α 28.7±1.6 pg/ml, IFN-γ 5.9±0,3 pg/ml vs. 59.9±4.1 pg/ml and 5.9±0.6 pg/ml in controls, p< .05). Levels of pro-allergic cytokines IL-4 and IL-13 in asthmatic children showed substantial increase during URTI (IL-4: 0.8±0.1 pg/ml vs. 0.5±0.1 pg/ml in controls initially, 1.5±0.3 pg/ml vs. 0.5±0.1 pg/ml in controls, p< 0.01 in the late disease; IL-13: 12.6±2.8 pg/ml vs. 2.5±0.4 pg/ml in controls, and 23.2±2.3 pg/ml vs. 2.8±0.2 pg/ml in controls, in the early and late disease, resp.; p< .001).
Conclusion. Results of the study revieled that not only intensification of allergic inflammation but also depression of interferon response during viral URTIs is typical for asthmatic children.
Th1 of the immune response type, involved in the formation and destabilization of the atheromatous plaque [5] . Due to structural and functional remodeling, activation of neuro-humoral systems and reactions involving inflammatory molecules in patients with coronary artery disease, the disruption of systolic function of the left ventricle (LV) is formed. The biomechanical reorganization of the heart causes changes in the expression of genes that mediate CSI, apoptotic reactions, etc. [6] . Therefore, it is expedient to study in detail the molecular mechanisms of atherogenesis in order to find new targets for pharmacological effects in CA and CHD. The aim of our research was to examine the relationship between the level of CSI and central hemodynamic disorders in patients with coronary heart disease.
Materials and Methods. 230 patients with CHD were examined: stable angina pectoris, II FC, CH 0-I (119 men and 111 women aged 57 + 8.3 years) and 30 healthy subjects (control group). The criteria for inclusion in the study were the age of men and women (40-75 years), the presence of CHD: exertional angina of II FC in the absence of destabilization of the course for at least two months, the informed consent of the patient to participate in the study. The exclusion criteria were the presence of chronic heart failure higher than stage I, high blood pressure, complications of cardiac rhythm and conduction disorders, rheumatism, cancer, anemia, diabetes mellitus, renal and hepatic insufficiency. To achieve the aim of the research, patients' blood was tested for levels of IL-1β and TNFα by the immune enzyme method; fibrinogen (FG) plasma levels -by weight method and echocardiography (echo) Results. In patients with coronary heart disease, an increase in the concentration of pro-inflammatory CK was found in the blood: the TNFα level was 8.48 + 2.15 pg / ml, and the level of IL-1β was 9.34 + 2.80 pg / ml. In 37.4% of patients with coronary heart disease, high levels of FG in the blood plasma were observed. In patients with coronary heart disease, EF of LV, SV and v of EP of LV were significantly lower in comparison with the group of healthy individuals (p <0.05). The ratio of transmitral blood flow phases in patients with coronary heart disease was disrupted -E / A <1, the DT value was increased (p <0.05), IVRT was delayed (p <0.05). The clinical evaluation of echo results showed that LV diastolic dysfunction was detected in 99% of patients with CHD by the type of relaxation disturbances, 1.6% -by the type of pseudonormalization. The study of the ratio in the indices of central hemodynamics and CSI markers revealed the reverse correlation between EF of LV and TNFα (r = -0.340, p <0.05), EF of LV and FG (r = -0.3369, p <0.01), the E / A value and IL-1β (r = 0.333, p <0.05). Conclusion. The obtained results demonstrate the negative effect of CSI on the systolic and diastolic function of LV in patients with coronary heart disease.
Prospects for further research. Further study of the levels of pro-inflammatory CK and other markers of inflammation in patients with CA and CHD can be the basis for constructing a diagnostic algorithm to determine the predictors of destabilization of the course and progression of the specified pathology and the development of optimal pathogenetically substantiated therapies.
Recommendations. It is expedient to use the levels of CK and FG in the blood as diagnostic and prognostic markers for assessing the course of coronary heart disease, the progression of CA and the effectiveness of therapeutic measures.
